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Brief Research Reportsundefined, associationwith deterioration in cognitive function
6 months after CAS has been reported.4 Currently, no protec-
tion device can completely prevent distal embolization. Fur-
thermore, dislodgement of embolic debris can occur during
guidewire manipulation and protection device positioning or
removal. Determining the risk factors for embolization could
lead to a better patient selection, improving outcomes ofCAS.
Unstable, echolucent atherosclerotic plaques have been
associated with increased embolic potential and increased
risk of stroke in CAS.5 This study confirms the increased
embolic potential, because we found a significantly higher
number of embolic particles when CAS was performed in
the first weeks after symptoms and a significantly higher
number of particles in atheromatous plaques.
Older age, hypertension, hypercholesterolemia, coronary
artery disease, symptomatic lesions, number of balloon
dilations, and stent diameter have unequivocally been asso-
ciated with increased embolic potential. In this study, we
found only smoking to be negatively correlated with the
number of dislodged particles during CAS. A possible ex-
planation for this finding is that plaque composition in
smokers differs from nonsmokers because of different etiol-
ogy, and these plaques could be more stable.
Because of the method of histologic processing and sec-
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The Journal of Thoracic and Caappeared in the qualitative analysis. In addition to the small
sample size, this is a limitation of this study.
CONCLUSIONS
The detailed analysis of embolic debris and the findings
that lesion characteristics and timing of intervention seem
to be the most important factors influencing distal emboli-
zation during CAS and contribute to further understanding
the mechanism of embolization and better patient
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General anesthesia is commonly used for video-assisted
thoracic surgery (VATS) with talc pleurodesis, although
use of regional anesthesia in the awake patient mightimprove outcomes.1,2 The purpose of this randomized
study is to compare the hospital discharge of patients
undergoing VATS with talc pleurodesis using thoracic
epidural or general anesthesia.CLINICAL SUMMARY
Forty patients with malignant pleural effusion were
randomized to undergo VATS with talc pleurodesis by
awake anesthesia with thoracic epidural (awake group,
N ¼ 20) or general anesthesia and 1-lung ventilation
(control group, N ¼ 20) (ClinicalTrials.gov registration
No. NCT01469728). The study was approved by the Po-
liclinico Tor Vergata University ethical committee, and
written informed consent was obtained by the patients.
Eligibility criteria are summarized in Table E1.
In the awake group, the thoracic epidural catheter was in-
serted at the T4 level for continuous infusion of ropivacainerdiovascular Surgery c Volume 146, Number 2 495
FIGURE 1. Daily amount of drainage volume (left) and histogram detailing hospital stay (right) in the study groups. TEA, Thoracic epidural anestesia.
Brief Research Reportsplus sufentanil. Patients remained conscious during the
procedure.
In the control group, general anesthesia was induced by
propofol with a single dose of cisatracurium for muscle re-
laxation. One-lung ventilation was achieved by a left-sided
double-lumen tube.
The surgical procedure was performed through a single
flexible trocar. After evacuation of the effusion, 5 g of
asbestos-free talc powder was insufflated under visual
control onto the entire pleural surface. After surgery,
the chest tube was placed on 20 cmH2O suction, and in
the awake group, the epidural catheter was removed
within 24 hours. Criteria for discharge were standardized
and included 24/hour fluid drainage less than 200 mL.
During the follow-up, a chest x-ray was performed at 1
month.
The primary outcome was early hospital discharge (hos-
pital stay 3 days). Secondary outcome measures included
assessment of the daily drainage volume, oxygenation mea-
sures, postoperative pain, in-hospital charges, need for redo
drainage, and survival. Patients’ satisfaction with the as-
signed anesthesia protocol was graded according to an ordi-
nal scale ranging from 4 (optimal) to 1 (unsatisfactory).TABLE 1. Main results
Awake group Control group P value
Operative time (min) 30  8 29  5 .63
Anesthesia satisfaction (score) 2.8  1.0 2.4  0.7 .19
24-h pain VAS (score) 1.7  0.5 2.1  0.8 .16
24-h PaO2/FIO2 (mm Hg) 325  33 326  24 .96
24-h PaCO2 (mm Hg) 42  2 42  3 .60
Hospital stay (d) 3.8  1.7 4.3  1.5 .07
Early discharge (3 d) 15 7 .02
Procedure-related cost (euros) 3015  1450 3780  1170 <.00001
Redo drainage (N) 2 3 .66
Survival (mo) 5.1 6 .8
VAS, Visual analogue scale; PaO2/FIO2, ratio of arterial oxygen tension to fraction of
inspired oxygen; PaCO2, arterial carbon dioxide.
496 The Journal of Thoracic and Cardiovascular SurgFor the study purpose, 20 patients per group were calcu-
lated to be necessary by a 2-tailed test assuming a 2.5-fold
increase of early discharges using regional anesthesia
(a ¼ 0.05; power ¼ 0.80).
The nonparametric Mann–Whitney test and 2-tailed
Fisher exact test were used to match averaged data and
proportions, respectively. Survival was assessed by the
Kaplan–Meier method.RESULTS
There were no intergroup differences in demographics
and baseline characteristics (Table E2). No patient in the
awake group required sedation or conversion to general an-
esthesia. Hospital mortality included 1 patient in the control
group who died of cancer progression.
The proportion of early discharges was significantly
greater in the awake group. In addition, the drainage volume
24 hours after surgery and procedure-related costs were bet-
ter in the awake group, whereas oxygenation, postoperative
pain, mortality, effusion recurrence, and survival were com-
parable between groups (Figure 1 and Table 1).DISCUSSION
The most striking result of this study is that VATS with
talc pleurodesis performed using awake anesthesia with
thoracic epidural resulted in a significantly greater propor-
tion of early discharges than procedures performed using
general anesthesia. Reasons underlying such a beneficial ef-
fect are conjectural and include better control of the pleural
space with more rapid lung reexpansion, which may be due
to superior perioperative pain relief or reduced barotrauma
and volutrauma under spontaneous ventilation. The more
frequent early discharges achieved in the awake group even-
tually resulted in lower costs, whereas the need for redo
drainage and survival were comparable between study
groups.
Excellent results have been reported for VATS with talc
pleurodesis performed using intercostal blocks andery c August 2013
Brief Research Reportssedation.2 We prefer epidural anesthesia because it provides
a wider thoracic analgesia than local anesthesia and obvi-
ates the need for adjunctive sedation. Furthermore, mainte-
nance of consciousness is useful at the end of the procedure
when lung reexpansion can be achieved physiologically by
the patient through repeated coughing.3 Other supposed
benefits of epidural anesthesia include increased myocar-
dial blood flow, reduced rate of thromboembolic events,
and attenuation of humoral stress response.4 On the other
hand, epidural anesthesia-related complications, such as
the risk of epidural hematoma, must be acknowledged, par-
ticularly in patients with coagulation disorders.
Alternative options for management of malignant pleural
effusion include bedside talc slurry and use of indwelling
catheters placed in the outpatient setting, which hold prom-
ise5 and should be compared with awake VATS pleurodesis
in the near future.
Limitations of our study include the use of a dichoto-
mized continuous variable as a primary outcome mea-
sure, which was chosen intentionally to ensure that the
trial had sufficient power with a limited, single-center
cohort.
CONCLUSIONS
Awake VATS with talc pleurodesis resulted in a greater
proportion of early discharges and eventually lower costs
than procedures performed with general anesthesia. FurtherThe Journal of Thoracic and Cadata from larger studies will be necessary to corroborate our
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APPENDIX
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Fabrizio Sabato, MD, Elisabetta Sabato, MD, Cesare Salt-
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TABLE E1. Inclusion criteria
Free-flowing unilateral pleural effusion on chest computed tomography
occupying at least one third of the hemithorax in patients with recent
history of malignancy.
Karnofsky performance status 50
ASA score II-III
Acceptance of randomized assignment to the anesthesia protocol
Absence of coagulation disorders (INR<1.5)
No contraindications for thoracic epidural anesthesia
No neurologic or psychiatric disturbance contraindicating awake
anesthesia during surgery
ASA, American Society of Anesthesiology; INR, international normalized ratio.
TABLE E2. Demographics and baseline data
Awake group Control group P value
Age, y 67  12 67  10 .95
M/F ratio 13/7 10/10 .34
Lung cancer/other histology 6/14 11/9 .20
PaCO2 (mm Hg) 42  3 41  3 .44
PaO2/FIO2 (mm Hg) 328  33 328  26 .97
FEV1 (L) 1.94  0.7 1.92  0.5 .91
FEV1 (% predicted) 79  13 78  14 .85
FVC (L) 2.6  0.7 2.7  0.7 .72
FVC (% predicted) 79  14.5 80  14 .85
FEV1/FVC ratio 0.73  0.1 0.71  0.1 .54
PEF (L/min) 300  45 298.5  70 .90
PEF (% predicted) 87  10 86  14 .21
ASA III (rate) 12/20 11/20 1.0
Karnofsky score 66  10 67  10 .7
Brief Research ReportsOrdinal variables are expressed as mean standard deviation. PaCO2, Arterial carbon
dioxide; PaO2/FIO2, ratio of arterial oxygen tension to fraction of inspired oxygen;
FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; PEF, peak
expiratory flow; ASA, American Society of Anesthesiology score (range I-IV).497.e1 The Journal of Thoracic and Cardiovascular Surgery c August 2013
